Akɔntínkpo sín azɔn nɔ nyí nǔ e nɔ huzu ɖò nǔwiwa kpo nǔwiwa agbaza tɔn kpo e nɔ jɛ ɖò kansɛ́n kansɛ́n tɔn sín nukɔn yì wɛ lɛ é mɛ é.
Azɔnkwín zò mɛ tɔn nyí azɔn syɛnsyɛn ɖé bɔ nǔwukpikpé è ɖó bo na kpé nukún dó nǔ wu é kpo nǔwukpikpé è ɖó bo na má agbaza ɔ tɔn lɛ é kpo nɔ zɔ́n bɔ é nɔ wá syɛn.
Kú enɛ lɛ sixu huzu ada bo gbakpé agbaza sín akpáxwé ɖevo lɛ mɛ, bo dɔn azɔn alɔkpa alɔkpa lɛ kpo nǔ e nɔ bɔ è nɔ mɔ wuvɛ̌ lɛ é kpo wá.
Akpáxwé vovo wɛ nɔ zɔ́n bɔ è nɔ ɖó kansɛ́n huhu tɔn, ɖi ɖyɔɖyɔ nǔɖògbɛ e è jì lɛ é, nǔ ɖěɖee nɔ wà nǔ dó gbɛzán mɛ wu lɛ é kpo.
Genetic mutations sixu wá ɖò DNA tɔn e ɖò hǔnzɔn lɛ mɛ é mɛ, bo nɔ zɔ́n bɔ hǔnzɔn lɛ nɔ sù bo nɔ má yeɖée ɖò ali e è ma ɖó acɛ tɔn ǎ é.
È sixu ɖu gǔ enɛ lɛ tɔn alǒ è sixu ɖó ye, bɔ nǔ e nɔ zɔ́n bɔ è nɔ jɛ azɔn baɖabaɖa lɛ é ɖi azɔ nunu, radon, azěbizɔ́si, kpo jɔhɔn blíblí kpo sixu zɔ́n bɔ è nɔ ɖó ye.
È hɛn ɔ è na má kansɛ́n akpaví lɛ dó alɔkpa we ta: kansɛ́n akpaví e ɖó xwɛ kpɛví lɛ é (SCLC) kpo kansɛ́n akpaví e ɖó xwɛ kpɛví ǎ lɛ é (NSCLC).
Akpáxwé è nɔ dó azɔn baɖabaɖa nú agbaza mɛ lɛ é sixu gbɔn vo ɖó ye ɖó jijɔ nùɖé lɛ tɔn vovo lɛ bo nɔ ɖí xwi xá amasin lɛ gbɔn vo.
Akpáxwé nǔ nɔ wà dó lanmɛ wu ɖò kansɛ́ɛ́ɛ mɛ lɛ é lɔ nɔ byɔ ɖɔ kansɛ́ɛ́ɛ kpo nǔ e lɛ́ lɛ̌ dó ye lɛ é kpo, kaka jɛ lanmɛ cyɔ́n alɔ mɛ nú mɛ jí lɛ é kpo ni wà nǔ ɖó kpɔ́.
Azɔnkɔntɔ́ lɛ sixu gló lanmɛ syɛnsyɛn sín azɔwanú e nɔ cyɔn alɔ mɛ jí lɛ é, bɔ ye na sù bo gbakpé ma ɖó dogbó ǎ.
Gɔ́ na ɔ, nǔ kpɛví e ɖò lanmɛ ɔ mɛ lɛ é sixu zɔ́n bɔ lanmɛ ɔ́ nɔ sù bo nɔ lɛ́ gbló ada, ɖó ye nɔ dó wusyɛn lanmɛ nú kansɛ́ɛ́li lɛ.
Akɔntínkpo sín azɔn nɔ nyí nǔ ɖé bɔ nǔ lɛ nɔ ɖyɔ, bɔ nǔnywɛ xwitixwiti-tɔ́ lɛ ɖò azɔ̌ wà wɛ hwebǐnu bo na mɔ nukúnnú jɛ nǔ e ɖò jijɛ wɛ lɛ é wu, bo na dó sixu kpé nukún dó azɔn wu ganji, bo lɛ́ na dó gbɔ azɔn nú azinzɔnnɔ lɛ.
Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.
Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.
Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.
Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .
Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .
Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.
['Nǔgbɛnúmɛ: dotóoxwé sín']
['Nǔkplɔnkplɔn kpo nǔsisɔ kpo sín azɔ̌ kɛɖɛ wɛ è nɔ wà dó tɛn ɛntɛnɛti tɔn elɔ jí, bo nɔ na wěɖexámɛ dotóoxwé tɔn alǒ azɔ̌ ɖevo lɛ mɛ ǎ.']
['È ɖó na zán nǔ e è kplɔ́n mɛ lɛ é dó ba azɔn ɖé alǒ azɔn ɖé sín wuntun alǒ dó gbɔ na ǎ, bɔ mɛ ɖěɖee jló na ba wěɖexámɛ dotóo tɔn lɛ é ɖó na yì mɔ dotóo e ɖó acɛ bo nɔ wà azɔ̌ ɖò dotóoxwé é ɖé.']
['Mi ni flín ɖɔ nǔ e è nɔ ylɔ ɖɔ "neural net" bo nɔ na xósin nú nǔkanbyɔ lɛ é ɔ, nǔ e nɔ nyí nǔjɛdo tawun é wɛ nyí nǔ ɖěɖee è nɔ ylɔ ɖɔ "numeric content" lɛ é. Ði kpɔ́ndéwú ɔ, mɛ nabi è mɔ azɔn ɖé na é.']
['Nɔ ba wěɖexámɛ dotóo towe tɔn alǒ dotóo ɖevo e ɖó nǔwukpikpé é tɔn dó azɔn ɖé wu hwebǐnu. Ma wɔn wěɖexámɛ dotóo tɔn lɛ gbeɖé ó, alǒ ma lin tamɛ kpɔ́n dó nǔ e a xà ɖò tɛn ɛntɛnɛti tɔn elɔ jí lɛ é wu ó. Enyi a lin ɖɔ azɔn baɖabaɖa ɖé ɖò xwi ɖí xá we wɛ hǔn, ylɔ 911 alǒ yì dotóoxwé e sɛkpɔ we hugǎn é tlolo. Tɛn ɛntɛnɛti tɔn elɔ alǒ nǔ e a nɔ zán lɛ é nɔ zɔ́n bɔ kancica dotóo-azinzɔnnɔ ɖé tɔn nɔ tíìn ǎ. BioMedLib, azɔ̌watɔ́ tɔn lɛ, alǒ mɛ ɖevo ɖebǔ e nɔ wlan nǔ dó tɛn ɛntɛnɛti tɔn elɔ jí lɛ é nɔ ɖè kúnnuɖenú ɖebǔ xlɛ́, bo tlɛ nɔ ɖɔ lɔ ǎ, dó nǔ e è ɖɔ ɖò fí lɛ é alǒ nǔ e è nɔ zán lɛ é wu.']
['Nǔɖògbɛ́jlatɔ́ lɛ']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nɔ na acɛ mɛ e ɖó nǔɖokan yetɔn lɛ é bɔ ye na dó ba nǔɖe bo dó sixu mɔ nǔ e ye ɖó lɛ é ɖò Internet jí.']
["Enyi a ɖi nǔ ɖɔ nǔ ɖĕbǔ ɖò tɛn ɛntɛnɛti tɔn mǐtɔn jí alǒ azɔ̌wiwa mǐtɔn lɛ jí bo hɛn nǔ dó así nú mɛ ɔ, é xò nǔ dó acɛ nǔɖògbɛ́ towe lɛ wu ɔ, hwi (alǒ mɛ e nɔ kpé nukún dó wǔ towe é) sixu sɛ́ wɛn dó mǐ, bo byɔ ɖɔ mǐ ni ɖè nǔ ɖ'emɛ lɛ sín tɛn ɔ jí, alǒ ɖɔ mǐ ni sú ali dó mɛ."]
["È ɖó ná sɛ́ mɛ dó gbɔn email jí (e-mail è nɔ dó ɔ́' kpɔ́n 'Kɔntaktɔ́' ɔ́)."]
['DMCA byɔ ɖɔ ɖɔ nǔ elɔ lɛ ni nɔ akpáxwé nǔ e a ɖɔ é gbà acɛ dó nǔ é tɔn jí é: (1) xó dó azɔ̌ e ɖó acɛ dó nǔ é jí; (2) xó dó nǔ e ɖó acɛ dó nǔ é jí, kpo nǔ ɖevo e na zɔ́n bɔ mǐ na mɔ nǔ ɔ lɛ é kpo; (3) xó dó hwiɖée wu, ɖi adlɛsi towe, alokan towe kpo email towe kpo; (4) xó ɖɔ dó nǔ e wu a ɖi nǔ ɖɔ nǔ e ɖó acɛ dó nǔ e jí a ɖɔ é jí é kún nyí nǔ e ɖó acɛ dó nǔ é jí tɔn ɔ, alǒ mɛ e nɔ kpé nukún dó nǔ é tɔn wu é sín acɛ ó; ']
["(5) Ðɛ́ mɛ̀ è mi sɔ́ alɔ dó ɖ'así ná ɖò hwɛɖɔxɔsá ɔ́' è ɖó ná ɖó hwɛ̀ ɖɔ̀ xó è mi ɖɔ ɖò mɛ̀ è mi dó wèmá ɔ́ mɛ̀ ɔ́' sɔgbe bɔ̀ mi ɖó acɛ̀ bó ná dó ba ɖɔ è ní sú nǔ è è dó wèmá ɔ́ wú lɛ́ɛ sín axɔ́."]
['bɔ (6) alɔ wlanwlan mɛ e ɖó acɛ dó nǔ é tɔn alǒ mɛ e ɖó acɛ bo na wà nǔ dó wutu tɔn é tɔn. ']
['Nú a ma gɔ́ nǔ e ɖò jí lɛ é bǐ ǎ ɔ, é sixu zɔ́n bɔ è na lín có bo na dóhwɛ we.']
['Wǎ kpé mì']
['Mi kɛnklɛn bo sɛ́ nǔkanbyɔ mitɔn lɛ dó mǐ gbɔn e-mail jí.']
What is pathophysiology of lung cancer?
The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.
Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.
These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.
The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.
Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.
These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.
Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.
The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.
Cancer cells can evade the immune system, allowing them to grow and spread unchecked.
Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.
The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['E ɖò']
['BioMedLib nɔ zán ordinateur lɛ (algorithme nǔ kplɔnkplɔn mɔto tɔn lɛ) bo nɔ dó kàn nǔ byɔ mɛ lɛ bo nɔ lɛ́ na ye xósin.']
['Mǐ bɛ́ kpodo azɔwanú lanmɛ kpo lanmɛ kpo tɔn livi 35 e ɖò PubMed/Medline lɛ é kpo. Mǐ lɛ́ vɔ́ mɔ tɛn ɛntɛnɛti tɔn RefinedWeb tɔn lɛ.']
